Skip to main content
Search results
https://www.fda.gov/drugs/biosimilars/biosimilar-product-information
7 months ago -
Information Ahzantive (aflibercept-mrbb) June 2024 Eylea (aflibercept) Ahzantive Information...Diseases Yesafili (aflibercept-jbvf) May 2024 Eylea (af ...
https://www.fda.gov/media/166780/download
over 1 year ago -
Review of BLA 125387/s-075: Eylea (Aflibercept)...Review of BLA 125387/s-075: Eylea (Aflibercept) Clinical Summary Review Wiley A...7, 2023 ...
https://www.fda.gov/drugs/news-events-human-drugs/notable-approvals-drugs
5 months ago -
...5/20/2024 Yesafili and Opuviz aflibercept-jbvf and aflibercept-yszy FDA approves first
https://www.fda.gov/media/168488/download
over 1 year ago -
Evaluation Clinical Studies (Eylea (aflibercept) Injection)...Evaluation Clinical Studies (Eylea (aflibercept) Injection) U.S. Department of ...
https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-interchangeable-biosimilars-eylea-treat-macular-degeneration-and-other-eye
5 months ago -
...approved Yesafili (aflibercept-jbvf) and Opuviz (aflibercept-yszy) as interchangeable...interchangeable biosimilars to Eylea (aflibercept)....approved ...
https://www.fda.gov/media/177082/download
10 months ago -
O 8/18/2023 BLA 761355 EYLEA HD AFLIBERCEPT REGENERON PHARMACEUTICALS, INC.
https://www.fda.gov/media/177086/download
10 months ago -
...125387 75 New Indication EYLEA (AFLIBERCEPT) REGENERON PHARMACEUTICALS, INC
https://www.fda.gov/media/168199/download
almost 2 years ago -
...license application (sBLA) 125387, aflibercept solution for intravitreal injection...written request was for studies of aflibercept in the treatment ...
https://www.fda.gov/media/164373/download
about 2 years ago -
Advisory Committee Meeting Eylea (aflibercept) Treatment of Retinopathy of Prematurity...orphan designation (July23, 2019) of aflibercept for the ...
https://www.fda.gov/media/164374/download
about 2 years ago -
Advisory Committee Meeting CO-1 EYLEA® (aflibercept) for the Treatment of Retinopathy...Current US adult indications for aflibercept 2 mg ▪ ...
https://www.fda.gov/media/164339/download
about 2 years ago -
Advisory Committee Meeting EYLEA® (AFLIBERCEPT) INJECTION FOR RETINOPATHY OF PREMATURITY...AVAILABLE FOR PUBLIC RELEASE Regeneron Aflibercept ...
https://www.fda.gov/media/164338/download
about 2 years ago -
...125387/S-075 Eylea (aflibercept) BLA 125387/S-075 Aflibercept Retinopathy of Prematurity...Supplement 75 Established/Proper Name Aflibercept Trademark ...
https://www.fda.gov/media/168200/download
almost 2 years ago -
Pharmaceuticals, Inc. 12 EYLEA® (aflibercept) for the Treatment of 13 Retinopathy...66 5 FDA Presentations 6 EYLEA (aflibercept) 7 Treatment of ...
https://www.fda.gov/media/164370/download
about 2 years ago -
...license application (sBLA) 125387, aflibercept solution for intravitreal injection...written request was for studies of aflibercept in the treatment ...
https://www.fda.gov/media/164333/download
about 2 years ago -
...license application (sBLA) 125387, aflibercept solution for intravitreal injection...written request was for studies of aflibercept in the treatment ...
https://www.fda.gov/media/168487/download
over 1 year ago -
Review) Brand Name EYLEA Generic Name Aflibercept Dosage Form and Strength Iso-osmotic...ID: 5087130 1. EXECUTIVE SUMMARY Aflibercept (EYLEA) is a ...
https://www.fda.gov/media/173980/download
9 months ago -
VIAL Trade Name: EYLEA Proper Name: AFLIBERCEPT Total Drug Content (Concentration)...Trade Name: EYLEA HD Proper Name: AFLIBERCEPT Total Drug Content ...
https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-vabysmo
about 1 year ago -
...the other half with aflibercept for two years. Aflibercept is an approved drug...and one third were treated with aflibercept. Both drugs were injected ...
https://www.fda.gov/media/175253/download
about 1 year ago -
...type of white blood cell). • Eylea (aflibercept) injection was originally approved
https://www.fda.gov/media/164372/download
about 2 years ago -
DISCUSSION: Discuss how the studied use of aflibercept in the treatment of retinopathy
